CompaniesGenVec

GenVec

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (9)
View all

Total Trials

9

As Lead Sponsor

9

As Collaborator

0

Total Enrollment

149

By Phase

PHASE2: 4PHASE3: 1PHASE1: 2PHASE1/PHASE2: 2

By Status

COMPLETED: 8UNKNOWN: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT00215696
Hover over trial bars to see details

Recent Trials

NCT00215696Lead Sponsor
A Study to Treat Patients Whose Chronic Angina Symptoms Are Not Relieved by Medication and Have an Area of the Heart That Cannot be Treated by Standard Therapies
PHASE2Completed
129 participants
Started: Apr 30, 2005
NCT00051467Lead Sponsor
A Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer
PHASE3Completed
NCT00051480Lead Sponsor
Study of TNFerade™ Gene Therapy, Radiation, 5-FU and Cisplatin in Esophageal Cancer
PHASE2Completed
NCT00109499Lead Sponsor
Study of AdGVPEDF.11D in Neovascular Age-related Macular Degeneration (AMD)
PHASE1Completed
NCT00137878Lead Sponsor
TNFerade™ Plus Chemo/Radiation/Surgery for Rectal Cancer
PHASE2Completed
View all 9 trials →
Funding History (20)
8-K
Jun 16, 2017
Filing
8-K
Jun 15, 2017
Filing
8-K
May 17, 2017
Filing
DEFM14A
May 12, 2017
Filing
DEFA14A
Jan 24, 2017
Filing
8-K
Jan 24, 2017
Filing
8-K
Dec 16, 2016
Filing
8-K
Dec 1, 2016
Filing
8-K
Nov 16, 2016
Filing
8-K
Nov 4, 2016
Filing